Home › Funds › ACUTA CAPITAL PARTNERS, LLC › ROIV
ACUTA CAPITAL PARTNERS, LLC position in ROIV
ROIVANT SCIENCES LTD · Health Care
ACUTA CAPITAL PARTNERS, LLC reported holding 41,535 shares of ROIV (ROIVANT SCIENCES LTD) in its Q3 2026 13F filing — a position valued at US$1.5M, representing 1.20% of its reported portfolio and ranking #23 among its reported holdings. ACUTA CAPITAL PARTNERS, LLC first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How ACUTA CAPITAL PARTNERS, LLC's ROIV position evolved
ACUTA CAPITAL PARTNERS, LLC first disclosed a stake in ROIV in Q3 2026 at 41,535 shares (US$1.5M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 41.53K | $1.52M | New |
About ROIV and 13F data
ROIV (ROIVANT SCIENCES LTD) is a Health Care company. 57 other funds we track also report a position in ROIV — the largest reported positions include QVT Financial LP (US$839.6M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$795.2M), Farallon Capital Management (US$506.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ROIV
- QVT Financial LP 23.72M sh · $839.56M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 21.75M sh · $795.23M · Q3 2026
- Farallon Capital Management 14.31M sh · $506.40M · Q2 2026
- ADAGE CAPITAL PARTNERS GP, L.L.C. 11.00M sh · $402.28M · Q3 2026
- PERCEPTIVE ADVISORS LLC 8.09M sh · $286.14M · Q2 2026
- Patient Square Capital LP 7.71M sh · $281.99M · Q3 2026
- Darwin Global Management, Ltd. 6.75M sh · $234.33M · Q2 2026
- Rubric Capital Management LP 6.00M sh · $212.34M · Q2 2026
- Nearwater Capital Markets, Ltd 5.60M sh · $204.79M · Q3 2026
- BAKER BROS. ADVISORS LP 4.72M sh · $166.93M · Q2 2026
- Affinity Asset Advisors, LLC 3.20M sh · $117.02M · Q3 2026
- ADAR1 Capital Management, LLC 3.08M sh · $112.62M · Q3 2026
More on ACUTA CAPITAL PARTNERS, LLC
FAQ
How long has ACUTA CAPITAL PARTNERS, LLC held ROIV?
ACUTA CAPITAL PARTNERS, LLC has disclosed ROIV holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is ACUTA CAPITAL PARTNERS, LLC's current position in ROIV?
As of Q3 2026, ACUTA CAPITAL PARTNERS, LLC holds 41.53K shares of ROIV (ROIVANT SCIENCES LTD), valued at $1.52M, representing 1.20% of its reported portfolio and ranking #23.
Has ACUTA CAPITAL PARTNERS, LLC been buying or selling ROIV?
In the latest 13F filing (Q3 2026), ACUTA CAPITAL PARTNERS, LLC newly opened its position in ROIV.
Which other funds hold ROIV?
Other major institutional holders of ROIV include QVT Financial LP, FARALLON CAPITAL MANAGEMENT, L.L.C., Farallon Capital Management, among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.